The effects of chiglitazar and metformin on insulin resistance in women with a normal BMI and polycystic ovary syndrome: a randomized controlled study

Abstract Background Polycystic ovary syndrome (PCOS) affects both obese and normal-weight women, with limited treatment options available for the nonobese population. Metformin (MET), an insulin sensitizer, is used to ameliorate insulin resistance and associated reproductive endocrine metabolic dysf...

Full description

Bibliographic Details

Main Authors:	Yining Yang, Yi Han, Jinhui Xu, Yijia Gao, Bing He
Format:	Artigo
Language:	Inglês
Published:	BMC 2025-12-01
Series:	BMC Endocrine Disorders
Subjects:	Polycystic ovary syndrome Normal weight Metformin Chiglitazar Insulin resistance
Online Access:	https://doi.org/10.1186/s12902-025-02082-0
Tags:	Add Tag No Tags, Be the first to tag this record!